A citation-based method for searching scientific literature

Yukti Choudhury, Min-Han Tan, Jun Li Shi, Augustine Tee, Kao Chin Ngeow, Jonathan Poh, Ruth Rosalyn Goh, Jamie Mong. Front Med (Lausanne) 2022
Times Cited: 3







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Non-Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman, Ankit Bharat, Debora S Bruno, Joe Y Chang, Lucian R Chirieac, Thomas A D'Amico,[...]. J Natl Compr Canc Netw 2022
82
66

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Pedram Razavi, Bob T Li, David N Brown, Byoungsok Jung, Earl Hubbell, Ronglai Shen, Wassim Abida, Krishna Juluru, Ino De Bruijn, Chenlu Hou,[...]. Nat Med 2019
317
66

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.
Aparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, Lipika Goyal, Chaya Levovitz, Giulia Siravegna, Dimitri Livitz, Kahn Rhrissorrakrai, Elizabeth E Martin, Emily E Van Seventer,[...]. Nat Med 2019
217
66

Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.
Christian Rolfo, Philip Mack, Giorgio V Scagliotti, Charu Aggarwal, Maria E Arcila, Fabrice Barlesi, Trever Bivona, Maximilian Diehn, Caroline Dive, Rafal Dziadziuszko,[...]. J Thorac Oncol 2021
104
66

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.
Natasha B Leighl, Ray D Page, Victoria M Raymond, Davey B Daniel, Stephen G Divers, Karen L Reckamp, Miguel A Villalona-Calero, Daniel Dix, Justin I Odegaard, Richard B Lanman,[...]. Clin Cancer Res 2019
264
66

Cell-free DNA captures tumor heterogeneity and driver alterations in rapid autopsies with pre-treated metastatic cancer.
Bernard Pereira, Christopher T Chen, Lipika Goyal, Charlotte Walmsley, Christopher J Pinto, Islam Baiev, Read Allen, Laura Henderson, Supriya Saha, Stephanie Reyes,[...]. Nat Commun 2021
14
66

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
66

Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice.
Charu Aggarwal, Christian D Rolfo, Geoffrey R Oxnard, Jhanelle E Gray, Lynette M Sholl, David R Gandara. Nat Rev Clin Oncol 2021
53
66

Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer.
Jürgen Wolf, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B Garon, Harry J M Groen, Daniel S W Tan, Toyoaki Hida, Maja de Jonge, Sergey V Orlov,[...]. N Engl J Med 2020
302
66

Tepotinib in Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations.
Paul K Paik, Enriqueta Felip, Remi Veillon, Hiroshi Sakai, Alexis B Cortot, Marina C Garassino, Julien Mazieres, Santiago Viteri, Helene Senellart, Jan Van Meerbeeck,[...]. N Engl J Med 2020
275
66

Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges.
Erika Rijavec, Simona Coco, Carlo Genova, Giovanni Rossi, Luca Longo, Francesco Grossi. Cancers (Basel) 2019
59
66


The GENIE Is Out of the Bottle: Landmark Cancer Genomics Dataset Released.
Kevin Litchfield, Samra Turajlic, Charles Swanton. Cancer Discov 2017
10
33

Clinical Implication of Liquid Biopsy in Colorectal Cancer Patients Treated with Metastasectomy.
Soohyeon Lee, Young-Soo Park, Won-Jin Chang, Jung Yoon Choi, Ahreum Lim, Boyeon Kim, Saet-Byeol Lee, Jong-Won Lee, Seon-Hahn Kim, Jin Kim,[...]. Cancers (Basel) 2021
4
33

A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers.
Joshua K Sabari, Michael Offin, Dennis Stephens, Andy Ni, Adrian Lee, Nick Pavlakis, Stephen Clarke, Connie I Diakos, Sutirtha Datta, Nidhi Tandon,[...]. J Natl Cancer Inst 2019
70
33

A Blood-based Assay for Assessment of Tumor Mutational Burden in First-line Metastatic NSCLC Treatment: Results from the MYSTIC Study.
Han Si, Michael Kuziora, Katie J Quinn, Elena Helman, Jiabu Ye, Feng Liu, Urban Scheuring, Solange Peters, Naiyer A Rizvi, Philip Z Brohawn,[...]. Clin Cancer Res 2021
43
33

Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer.
Kelly C S Oliveira, Iago Barroso Ramos, Jessica M C Silva, Williams Fernandes Barra, Gregory J Riggins, Vikrant Palande, Catarina Torres Pinho, Milana Frenkel-Morgenstern, Sidney E B Santos, Paulo P Assumpcao,[...]. Mol Cancer Res 2020
35
33

Life and death of circulating cell-free DNA.
Anatoli Kustanovich, Ruth Schwartz, Tamar Peretz, Albert Grinshpun. Cancer Biol Ther 2019
183
33

Molecular profiling for precision cancer therapies.
Eoghan R Malone, Marc Oliva, Peter J B Sabatini, Tracy L Stockley, Lillian L Siu. Genome Med 2020
228
33

Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
Andjelija Zivanovic Bujak, Chen-Fang Weng, Maria João Silva, Miriam Yeung, Louisa Lo, Sarah Ftouni, Cassandra Litchfield, Yi-An Ko, Keilly Kuykhoven, Courtney Van Geelen,[...]. PLoS Med 2020
11
33

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Markus Mayrhofer, Bram De Laere, Tom Whitington, Peter Van Oyen, Christophe Ghysel, Jozef Ampe, Piet Ost, Wim Demey, Lucien Hoekx, Dirk Schrijvers,[...]. Genome Med 2018
76
33

Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review.
Stepan M Esagian, Georgia Ι Grigoriadou, Ilias P Nikas, Vasileios Boikou, Peter M Sadow, Jae-Kyung Won, Konstantinos P Economopoulos. J Cancer Res Clin Oncol 2020
38
33

Liquid biopsy enters the clinic - implementation issues and future challenges.
Michail Ignatiadis, George W Sledge, Stefanie S Jeffrey. Nat Rev Clin Oncol 2021
270
33

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.
Seung Tae Kim, Razvan Cristescu, Adam J Bass, Kyoung-Mee Kim, Justin I Odegaard, Kyung Kim, Xiao Qiao Liu, Xinwei Sher, Hun Jung, Mijin Lee,[...]. Nat Med 2018
692
33


Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
Wael Al Zoughbi, Jesse Fox, Shaham Beg, Eniko Papp, Erika Hissong, Kentaro Ohara, Laurel Keefer, Michael Sigouros, Troy Kane, Daniel Bockelman,[...]. Oncologist 2021
4
33

Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non-Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel.
Zhijie Wang, Jianchun Duan, Shangli Cai, Miao Han, Hua Dong, Jun Zhao, Bo Zhu, Shuhang Wang, Minglei Zhuo, Jianguo Sun,[...]. JAMA Oncol 2019
273
33

Detection and quantification of rare mutations with massively parallel sequencing.
Isaac Kinde, Jian Wu, Nick Papadopoulos, Kenneth W Kinzler, Bert Vogelstein. Proc Natl Acad Sci U S A 2011
760
33

Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.
Charlotte Fribbens, Ben O'Leary, Lucy Kilburn, Sarah Hrebien, Isaac Garcia-Murillas, Matthew Beaney, Massimo Cristofanilli, Fabrice Andre, Sherene Loi, Sibylle Loibl,[...]. J Clin Oncol 2016
429
33

Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort.
Rafal Dziadziuszko, Tony Mok, Solange Peters, Ji-Youn Han, Jorge Alatorre-Alexander, Natasha Leighl, Virote Sriuranpong, Maurice Pérol, Gilberto de Castro Junior, Ernest Nadal,[...]. J Thorac Oncol 2021
9
33

Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living.
Ellen Heitzer, Lisa Auinger, Michael R Speicher. Trends Mol Med 2020
68
33

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1.
F André, E M Ciruelos, D Juric, S Loibl, M Campone, I A Mayer, G Rubovszky, T Yamashita, B Kaufman, Y-S Lu,[...]. Ann Oncol 2021
133
33

Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples.
Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti, Fabrizio Citarella, Francesco Pantano, Emanuela Dell'Aquila, Cecilia Anesi, Nicola Silvestris,[...]. J Exp Clin Cancer Res 2020
99
33

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer.
Alessandro Leal, Nicole C T van Grieken, Doreen N Palsgrove, Jillian Phallen, Jamie E Medina, Carolyn Hruban, Mark A M Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C Bruhm,[...]. Nat Commun 2020
88
33

Circulating tumor DNA as a liquid biopsy for cancer.
Ellen Heitzer, Peter Ulz, Jochen B Geigl. Clin Chem 2015
487
33

Clinical relevance of KRAS-mutated subclones detected with picodroplet digital PCR in advanced colorectal cancer treated with anti-EGFR therapy.
Pierre Laurent-Puig, Deniz Pekin, Corinne Normand, Steve K Kotsopoulos, Philippe Nizard, Karla Perez-Toralla, Rachel Rowell, Jeff Olson, Preethi Srinivasan, Delphine Le Corre,[...]. Clin Cancer Res 2015
121
33

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
Naiyer A Rizvi, Byoung Chul Cho, Niels Reinmuth, Ki Hyeong Lee, Alexander Luft, Myung-Ju Ahn, Michel M van den Heuvel, Manuel Cobo, David Vicente, Alexey Smolin,[...]. JAMA Oncol 2020
253
33

Analysis of circulating tumor DNA to confirm somatic KRAS mutations.
Matthias Holdhoff, Kerstin Schmidt, Ross Donehower, Luis A Diaz. J Natl Cancer Inst 2009
65
33

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).
Keith T Flaherty, Robert J Gray, Alice P Chen, Shuli Li, Lisa M McShane, David Patton, Stanley R Hamilton, P Mickey Williams, A John Iafrate, Jeffrey Sklar,[...]. J Clin Oncol 2020
82
33

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
33

Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications.
Hiu Ting Chan, Yoon Ming Chin, Yusuke Nakamura, Siew-Kee Low. Cancers (Basel) 2020
40
33

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.
Alexander W Wyatt, Matti Annala, Rahul Aggarwal, Kevin Beja, Felix Feng, Jack Youngren, Adam Foye, Paul Lloyd, Matti Nykter, Tomasz M Beer,[...]. J Natl Cancer Inst 2017
218
33

Clonal Architecture of EGFR Mutation Predicts the Efficacy of EGFR-Tyrosine Kinase Inhibitors in Advanced NSCLC: A Prospective Multicenter Study (NCT03059641).
Xinghao Ai, Jiuwei Cui, Jiexia Zhang, Rongrong Chen, Wen Lin, Congying Xie, Anwen Liu, Junping Zhang, Weihua Yang, Xiaohua Hu,[...]. Clin Cancer Res 2021
11
33

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.
Yongliang Zhang, Yu Yao, Yaping Xu, Lifeng Li, Yan Gong, Kai Zhang, Meng Zhang, Yanfang Guan, Lianpeng Chang, Xuefeng Xia,[...]. Nat Commun 2021
46
33


Fractionated small cell-free DNA increases possibility to detect cancer-related gene mutations in advanced colorectal cancer.
Yasuaki Ishida, Shinichi Takano, Shinya Maekawa, Tatsuya Yamaguchi, Takashi Yoshida, Shoji Kobayashi, Fumihiko Iwamoto, Toru Kuno, Hiroshi Hayakawa, Shuya Matsuda,[...]. JGH Open 2020
5
33

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, Hideaki Bando, Ken Kato, Chigusa Morizane, Taito Esaki, Yoshito Komatsu, Yasuyuki Kawamoto, Naoki Takahashi,[...]. Nat Med 2020
109
33

Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation.
Yanni Y N Lui, Ki-Wai Chik, Rossa W K Chiu, Cheong-Yip Ho, Christopher W K Lam, Y M Dennis Lo. Clin Chem 2002
306
33


Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.
Hanna Tukachinsky, Russell W Madison, Jon H Chung, Ole V Gjoerup, Eric A Severson, Lucas Dennis, Bernard J Fendler, Samantha Morley, Lei Zhong, Ryon P Graf,[...]. Clin Cancer Res 2021
46
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.